A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
暂无分享,去创建一个
Sebastiaan Overeem | Emmanuel Mignot | Seiji Nishino | Gert Jan Lammers | Mario Pedrazzoli | Michael Aldrich | William Rogers | Beth Ripley | Raju Kucherlapati | Yves Charnay | R. Kucherlapati | R. Albin | C. Bouras | R. Maki | M. Aldrich | E. Mignot | S. Nevsimalova | S. Overeem | M. Kucherlapati | Y. Charnay | M. Hungs | D. Reynolds | C. Peyron | J. Faraco | Robin Li | W. Rogers | S. Nishino | G. Lammers | Constantin Bouras | Muralidhara Padigaru | Marcel Hungs | Juliette Faraco | Sona Nevsimalova | M. Pedrazzoli | Christelle Peyron | B. Ripley | David Reynolds | M. Padigaru | Jun-Yang Fan | Robin Li | David Reynolds | Roger Albin | Melanie Kucherlapati | Jun Fan | Richard Maki | S. Nevšímalová
[1] T. Sakurai,et al. Structure and Function of Human Prepro-orexin Gene* , 1999, The Journal of Biological Chemistry.
[2] M. Ghatei,et al. Distribution and quantification of immunoreactive orexin A in rat tissues , 1999, FEBS letters.
[3] J. Battey,et al. Molecular analysis of autosomal dominant neurohypophyseal diabetes insipidus. , 1990, The Journal of clinical endocrinology and metabolism.
[4] Henry M. Kronenberg,et al. Inefficient Membrane Targeting, Translocation, and Proteolytic Processing by Signal Peptidase of a Mutant Preproparathyroid Hormone Protein (*) , 1995, The Journal of Biological Chemistry.
[5] E. Mignot,et al. Narcolepsy and immunity. , 1995, Advances in neuroimmunology.
[6] M. Billiard,et al. Autoimmune hypothesis in narcolepsy , 1993, Neurophysiologie Clinique/Clinical Neurophysiology.
[7] M. Nakazato,et al. Characterization of orexin-A and orexin-B in the microdissected rat brain nuclei and their contents in two obese rat models , 1999, Neuroscience Letters.
[8] D. Daly,et al. Narcolepsy in children. , 1960, Pediatrics.
[9] J. Montplaisir,et al. The effects of L-dopa on periodic leg movements and sleep organization in narcolepsy. , 1989, Clinical neuropharmacology.
[10] C. Bouras,et al. Mapping of cocaine and amphetamine regulated transcript (CART) mRNA expression in the hypothalamus of elderly human , 1999, Journal of Chemical Neuroanatomy.
[11] T. Hökfelt,et al. Hypocretin/Orexin‐ and melanin‐concentrating hormone‐expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and agouti gene‐related protein systems , 1998, The Journal of comparative neurology.
[12] S. Carr,et al. Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.
[13] D. Repaske,et al. Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23-->Val in neurophysin II. , 1997, The Journal of clinical endocrinology and metabolism.
[14] Sebastiaan Overeem,et al. Hypocretin (orexin) deficiency in human narcolepsy , 2000, The Lancet.
[15] Jon T. Willie,et al. Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.
[16] E. Mignot,et al. PHARMACOLOGICAL ASPECTS OF HUMAN AND CANINE NARCOLEPSY , 1997, Progress in Neurobiology.
[17] M. I. Smith,et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[18] C. Guilleminault,et al. Sleep/Wake Disorders: Natural History, Epidemiology, and Long-Term Evolution. , 1984 .
[19] C. Peyron,et al. The hypocretin/orexin ligand–receptor system: implications for sleep and sleep disorders , 2000, Trends in Neurosciences.
[20] Noth,et al. Dynamics of microglial activation in the spinal cord after cerebral infarction are revealed by expression of MHC class II antigen , 1998, Neuropathology and applied neurobiology.
[21] R. Scheller,et al. Three Novel Proteins of the Syntaxin/SNAP-25 Family* , 1998, The Journal of Biological Chemistry.
[22] M. Satake,et al. HLA antigens in Japanese patients with narcolepsy , 1984 .
[23] M. Satake,et al. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. , 1984, Tissue antigens.
[24] M. Aldrich,et al. Major Histocompatibility Class II Molecules in the CNS: Increased Microglial Expression at the Onset of Narcolepsy in a Canine Model , 1996, The Journal of Neuroscience.
[25] F E Bloom,et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Burbach,et al. Mutations in the Vasopressin Prohormone Involved in Diabetes Insipidus Impair Endoplasmic Reticulum Export but Not Sorting* , 1999, The Journal of Biological Chemistry.
[27] S. Carr,et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. , 1998, Cell.
[28] G. Paxinos,et al. Atlas of the Human Brain , 2000 .
[29] P. Underhill,et al. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. , 1994, Sleep.
[30] C. Guilleminault,et al. Narcolepsy in prepubertal children , 1998, Annals of neurology.
[31] Mignot,et al. Perspectives in narcolepsy and hypocretin (orexin) research. , 2000, Sleep medicine.
[32] A. N. van den Pol,et al. Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems , 1998, The Journal of Neuroscience.
[33] G. Barsh,et al. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area , 1998, The Journal of comparative neurology.
[34] Emmanuel Mignot,et al. The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene , 1999, Cell.
[35] C. Guilleminault,et al. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. , 1997, Sleep.
[36] E. Mignot,et al. Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[37] E. Mignot,et al. Genetic and familial aspects of narcolepsy , 1998, Neurology.
[38] George Kollias,et al. The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease , 1999, Annals of the rheumatic diseases.
[39] M. Ito,et al. Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum. , 1997, The Journal of clinical investigation.
[40] R. Hayduk,et al. Clinical and polysomnographic features in DQB1*0602 positive and negative narcolepsy patients: results from the modafinil clinical trial. , 2000, Sleep medicine.